LAVA Total Current Assets from 2010 to 2024

LVTX Stock  USD 1.61  0.01  0.63%   
LAVA Therapeutics Total Current Assets yearly trend continues to be fairly stable with very little volatility. Total Current Assets will likely drop to about 93.3 M in 2024. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
2018-12-31
Previous Quarter
96.7 M
Current Value
90.2 M
Quarterly Volatility
62.1 M
 
Covid
Check LAVA Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LAVA Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 158.4 K, Net Interest Income of 3.1 M or Depreciation And Amortization of 1.3 M, as well as many indicators such as Price To Sales Ratio of 5.93, Dividend Yield of 0.0 or PTB Ratio of 0.78. LAVA financial statements analysis is a perfect complement when working with LAVA Therapeutics Valuation or Volatility modules.
  
Check out the analysis of LAVA Therapeutics Correlation against competitors.

Latest LAVA Therapeutics' Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of LAVA Therapeutics NV over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. LAVA Therapeutics' Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LAVA Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Slightly volatile
   Total Current Assets   
       Timeline  

LAVA Total Current Assets Regression Statistics

Arithmetic Mean39,072,902
Geometric Mean17,040,118
Coefficient Of Variation137.43
Mean Deviation44,162,356
Median7,620,000
Standard Deviation53,699,070
Sample Variance2883.6T
Range147.1M
R-Value0.73
Mean Square Error1463.1T
R-Squared0.53
Significance0
Slope8,732,083
Total Sum of Squares40370.3T

LAVA Total Current Assets History

202493.3 M
202398.9 M
2022140.5 M
2021154.8 M
202022.4 M

About LAVA Therapeutics Financial Statements

LAVA Therapeutics investors use historical fundamental indicators, such as LAVA Therapeutics' Total Current Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LAVA Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Current Assets98.9 M93.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for LAVA Stock Analysis

When running LAVA Therapeutics' price analysis, check to measure LAVA Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LAVA Therapeutics is operating at the current time. Most of LAVA Therapeutics' value examination focuses on studying past and present price action to predict the probability of LAVA Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LAVA Therapeutics' price. Additionally, you may evaluate how the addition of LAVA Therapeutics to your portfolios can decrease your overall portfolio volatility.